 | • レポートコード：MRC23Q36277 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のプラスミドトランスフェクション試薬市場について調査・分析し、世界のプラスミドトランスフェクション試薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（リポソーム系試薬、非リポソーム系試薬）、用途別セグメント分析（基礎研究、創薬研究開発、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher、Promega、Qiagen、Polyplus-transfection、Lonza Group、Sigma、Mirus Bio、Takara Bio、Maxcyte、Navtechなどが含まれています。世界のプラスミドトランスフェクション試薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、プラスミドトランスフェクション試薬市場規模を推定する際に考慮しました。本レポートは、プラスミドトランスフェクション試薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、プラスミドトランスフェクション試薬に関するビジネス上の意思決定に役立てることを目的としています。 ・プラスミドトランスフェクション試薬市場の概要 - プラスミドトランスフェクション試薬のタイプ別セグメント - 世界のプラスミドトランスフェクション試薬市場規模：タイプ別分析（リポソーム系試薬、非リポソーム系試薬） - プラスミドトランスフェクション試薬の用途別セグメント - 世界のプラスミドトランスフェクション試薬市場規模：用途別分析（基礎研究、創薬研究開発、その他） - 世界のプラスミドトランスフェクション試薬市場規模予測（2018年-2029年） ・プラスミドトランスフェクション試薬市場の成長トレンド - プラスミドトランスフェクション試薬の地域別市場規模（2018年-2029年） - プラスミドトランスフェクション試薬市場ダイナミクス - プラスミドトランスフェクション試薬の業界動向 - プラスミドトランスフェクション試薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：リポソーム系試薬、非リポソーム系試薬 - 世界のプラスミドトランスフェクション試薬のタイプ別市場規模（2018年-2023年） - 世界のプラスミドトランスフェクション試薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：基礎研究、創薬研究開発、その他 - 世界のプラスミドトランスフェクション試薬の用途別市場規模（2018年-2023年） - 世界のプラスミドトランスフェクション試薬の用途別市場規模（2024年-2029年） ・プラスミドトランスフェクション試薬の地域別市場規模 - 北米のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - アメリカのプラスミドトランスフェクション試薬市場規模（2018年-2029年） - ヨーロッパのプラスミドトランスフェクション試薬市場規模（2018年-2029年） - アジア太平洋のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - 中国のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - 日本のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - 韓国のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - インドのプラスミドトランスフェクション試薬市場規模（2018年-2029年） - オーストラリアのプラスミドトランスフェクション試薬市場規模（2018年-2029年） - 中南米のプラスミドトランスフェクション試薬市場規模（2018年-2029年） - 中東・アフリカのプラスミドトランスフェクション試薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher、Promega、Qiagen、Polyplus-transfection、Lonza Group、Sigma、Mirus Bio、Takara Bio、Maxcyte、Navtech ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Plasmid Transfection Reagent market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Plasmid Transfection Reagent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Plasmid Transfection Reagent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Plasmid Transfection Reagent in Fundamental Research is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Plasmid Transfection Reagent include Thermo Fisher, Promega, Qiagen, Polyplus-transfection, Lonza Group, Sigma, Mirus Bio, Takara Bio and Maxcyte, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid Transfection Reagent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid Transfection Reagent.
The Plasmid Transfection Reagent market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasmid Transfection Reagent market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid Transfection Reagent companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher
Promega
Qiagen
Polyplus-transfection
Lonza Group
Sigma
Mirus Bio
Takara Bio
Maxcyte
Navtech
Segment by Type
Liposomal Based Reagents
Non-liposomal Based Reagents
Segment by Application
Fundamental Research
Drug Research and Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid Transfection Reagent companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Transfection Reagent Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liposomal Based Reagents
1.2.3 Non-liposomal Based Reagents
1.3 Market by Application
1.3.1 Global Plasmid Transfection Reagent Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Fundamental Research
1.3.3 Drug Research and Development
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Transfection Reagent Market Perspective (2018-2029)
2.2 Plasmid Transfection Reagent Growth Trends by Region
2.2.1 Global Plasmid Transfection Reagent Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid Transfection Reagent Historic Market Size by Region (2018-2023)
2.2.3 Plasmid Transfection Reagent Forecasted Market Size by Region (2024-2029)
2.3 Plasmid Transfection Reagent Market Dynamics
2.3.1 Plasmid Transfection Reagent Industry Trends
2.3.2 Plasmid Transfection Reagent Market Drivers
2.3.3 Plasmid Transfection Reagent Market Challenges
2.3.4 Plasmid Transfection Reagent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Transfection Reagent Players by Revenue
3.1.1 Global Top Plasmid Transfection Reagent Players by Revenue (2018-2023)
3.1.2 Global Plasmid Transfection Reagent Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid Transfection Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid Transfection Reagent Revenue
3.4 Global Plasmid Transfection Reagent Market Concentration Ratio
3.4.1 Global Plasmid Transfection Reagent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Transfection Reagent Revenue in 2022
3.5 Plasmid Transfection Reagent Key Players Head office and Area Served
3.6 Key Players Plasmid Transfection Reagent Product Solution and Service
3.7 Date of Enter into Plasmid Transfection Reagent Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Transfection Reagent Breakdown Data by Type
4.1 Global Plasmid Transfection Reagent Historic Market Size by Type (2018-2023)
4.2 Global Plasmid Transfection Reagent Forecasted Market Size by Type (2024-2029)
5 Plasmid Transfection Reagent Breakdown Data by Application
5.1 Global Plasmid Transfection Reagent Historic Market Size by Application (2018-2023)
5.2 Global Plasmid Transfection Reagent Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmid Transfection Reagent Market Size (2018-2029)
6.2 North America Plasmid Transfection Reagent Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid Transfection Reagent Market Size by Country (2018-2023)
6.4 North America Plasmid Transfection Reagent Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Transfection Reagent Market Size (2018-2029)
7.2 Europe Plasmid Transfection Reagent Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid Transfection Reagent Market Size by Country (2018-2023)
7.4 Europe Plasmid Transfection Reagent Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Transfection Reagent Market Size (2018-2029)
8.2 Asia-Pacific Plasmid Transfection Reagent Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid Transfection Reagent Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid Transfection Reagent Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Transfection Reagent Market Size (2018-2029)
9.2 Latin America Plasmid Transfection Reagent Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid Transfection Reagent Market Size by Country (2018-2023)
9.4 Latin America Plasmid Transfection Reagent Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Transfection Reagent Market Size (2018-2029)
10.2 Middle East & Africa Plasmid Transfection Reagent Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid Transfection Reagent Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid Transfection Reagent Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Plasmid Transfection Reagent Introduction
11.1.4 Thermo Fisher Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Promega
11.2.1 Promega Company Detail
11.2.2 Promega Business Overview
11.2.3 Promega Plasmid Transfection Reagent Introduction
11.2.4 Promega Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.2.5 Promega Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Plasmid Transfection Reagent Introduction
11.3.4 Qiagen Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.3.5 Qiagen Recent Development
11.4 Polyplus-transfection
11.4.1 Polyplus-transfection Company Detail
11.4.2 Polyplus-transfection Business Overview
11.4.3 Polyplus-transfection Plasmid Transfection Reagent Introduction
11.4.4 Polyplus-transfection Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.4.5 Polyplus-transfection Recent Development
11.5 Lonza Group
11.5.1 Lonza Group Company Detail
11.5.2 Lonza Group Business Overview
11.5.3 Lonza Group Plasmid Transfection Reagent Introduction
11.5.4 Lonza Group Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.5.5 Lonza Group Recent Development
11.6 Sigma
11.6.1 Sigma Company Detail
11.6.2 Sigma Business Overview
11.6.3 Sigma Plasmid Transfection Reagent Introduction
11.6.4 Sigma Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.6.5 Sigma Recent Development
11.7 Mirus Bio
11.7.1 Mirus Bio Company Detail
11.7.2 Mirus Bio Business Overview
11.7.3 Mirus Bio Plasmid Transfection Reagent Introduction
11.7.4 Mirus Bio Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.7.5 Mirus Bio Recent Development
11.8 Takara Bio
11.8.1 Takara Bio Company Detail
11.8.2 Takara Bio Business Overview
11.8.3 Takara Bio Plasmid Transfection Reagent Introduction
11.8.4 Takara Bio Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.8.5 Takara Bio Recent Development
11.9 Maxcyte
11.9.1 Maxcyte Company Detail
11.9.2 Maxcyte Business Overview
11.9.3 Maxcyte Plasmid Transfection Reagent Introduction
11.9.4 Maxcyte Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.9.5 Maxcyte Recent Development
11.10 Navtech
11.10.1 Navtech Company Detail
11.10.2 Navtech Business Overview
11.10.3 Navtech Plasmid Transfection Reagent Introduction
11.10.4 Navtech Revenue in Plasmid Transfection Reagent Business (2018-2023)
11.10.5 Navtech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
